Blood loss and subsequent transfusions are associated with major morbidity and mortality.
The use of antifibrinolytics can reduce blood loss in cardiac surgery, trauma, orthopedic …

Massive hemoptysis is regarded as a potentially lethal condition that requires immediate
attention, and prompt action. Although minor hemoptysis is frequently encountered by most …

It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

Chronic pulmonary aspergillosis (CPA) is an uncommon and problematic pulmonary
disease, complicating many other respiratory disorders, thought to affect∼ 240 000 people …

Background Tranexamic acid (TA) is an antifibrinolytic drug currently used systemically to
control bleeding. To date, there have been no prospective studies of the effectiveness of …

Background Hemoptysis, ie, the expectoration of blood from the lower airways, has an
annual incidence of approximately 0.1% in ambulatory patients and 0.2% in inpatients. It is a …

Abstract This CIRSE Standards of Practice document is aimed at interventional radiologists
and provides best practices for performing bronchial artery embolisation to effectively treat …

La hemoptisis es la expectoración de sangre proveniente del árbol traqueobronquial. Las
enfermedades que más frecuentemente la originan son las bronquiectasias, la bronquitis …

Hemoptysis is a frequent manifestation of a wide variety of diseases, with mild to life‐
threatening presentations. The diagnostic workup and the management of severe …

Background Tranexamic acid (TA) is used to control bleeding in patients with hemoptysis.
However, the effectiveness of the different routes of TA administration has not been studied …